Delivery Order SPE2DB20D3103-SPE2DB23FP2V3

Award Date 8/8/23
Potential Completion Date 8/9/23
Potential Value $12
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $23,260 delivery order to Amerisourcebergen Drug Corporation for 4561462519 ALBUTEROL 2.5 MG/0.5 ML SOL UDS. The firm fixed price order calls for the pharmaceutical products to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania to an unknown customer within one day, with performance spanning July 11-12, 2023. As a major division of Amerisourcebergen Corporation, the prime contractor will likely draw upon the corporation's extensive...
The Defense Logistics Agency awarded a $11,630 delivery order to Amerisourcebergen Drug Corporation for ALBUTEROL 2.5 MG/0.5 ML SOL UDS. The firm fixed price order is being performed in Conshohocken, Pennsylvania through July 2023 under the parent company Amerisourcebergen Corporation's corporate office division. No additional details were provided about the original solicitation, but the Defense Logistics Agency commonly issues requirements on behalf of the Department of Defense for...
The Defense Logistics Agency awarded a $11,630 delivery order to Amerisourcebergen Drug Corporation for 4561739064 ALBUTEROL 2.5 MG/0.5 ML SOL UDS. The prime contractor, a subsidiary of Amerisourcebergen Corporation, will provide the albuterol solutions from its facility in Conshohocken, Pennsylvania under a firm fixed price contract running from August 8 to August 9, 2023. No subcontractors or set aside designations were identified. This order is likely in support of DLA's medical supply...
The Defense Logistics Agency awarded a $11,630 delivery order to Amerisourcebergen Drug Corporation for 4561315629 ALBUTEROL 2.5 MG/0.5 ML SOL UDS. The firm fixed price contract calls for Amerisourcebergen to provide the albuterol solution from its facility in Conshohocken, Pennsylvania to the DLA by June 23, 2023. As a major supplier of pharmaceuticals and medical goods, Amerisourcebergen will support the DLA's mission to provide medical supplies to the U.S. military through this small purchase...
The Defense Logistics Agency awarded a $11,630 delivery order to Amerisourcebergen Drug Corporation for ALBUTEROL 2.5 MG/0.5 ML SOL UDS. The firm fixed price order is being fulfilled under the Prime Vendor Program and will provide the specified pharmaceutical product to DLA from Amerisourcebergen's facility located in Conshohocken, Pennsylvania. Performance will take place between June 27-28, 2023. No set aside designation or subcontractors were identified. This order supports DLA's mission to...
The Defense Logistics Agency awarded a $195,280 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ALBUTEROL 2.5 MG/0.5 ML SOL UDS. The order was placed under an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from July 5-6, 2023. As a leading pharmaceutical distributor, Amerisourcebergen...
The Defense Logistics Agency awarded a $11,630 delivery order to Amerisourcebergen Drug Corporation for 4561739077 ALBUTEROL 2.5 MG/0.5 ML SOL UDS. The prime contractor, a subsidiary of Amerisourcebergen Corporation, will provide the albuterol solutions from its facility in Conshohocken, Pennsylvania under a firm fixed price contract running from August 8 to 9, 2023. As a leading provider of pharmaceuticals and healthcare products to the U.S. Department of Defense, this order supports the...
The Defense Logistics Agency awarded a $11,630 delivery order to Amerisourcebergen Drug Corporation for 4561739068 ALBUTEROL 2.5 MG/0.5 ML SOL UDS. The firm fixed price order is being fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania under its corporate parent Amerisourcebergen Corporation. As a major distributor of pharmaceuticals and medical supplies, Amerisourcebergen will deliver the albuterol sulfate solution to support the DLA's procurement and distribution of...
The Defense Logistics Agency awarded a $11,630 delivery order to Amerisourcebergen Drug Corporation for 4561739076 ALBUTEROL 2.5 MG/0.5 ML SOL UDS. The firm fixed price order is being fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania under its corporate parent Amerisourcebergen Corporation. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for albuterol solutions supports the DLA's mission to provide critical medicines...
The Defense Logistics Agency awarded a $11,630 delivery order to Amerisourcebergen Drug Corporation for 4561739065 ALBUTEROL 2.5 MG/0.5 ML SOL UDS. The firm fixed price order is being fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania under the parent company Amerisourcebergen Corporation. As a major distributor of pharmaceuticals and medical supplies, Amerisourcebergen will deliver the albuterol solutions to support the DLA's procurement and distribution of medical...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FP2V3
    Delivery Order

The Defense Logistics Agency awarded a firm fixed price delivery order valued at $11,630 to Amerisourcebergen Drug Corporation to provide 4561739050 ALBUTEROL 2.5 MG/0.5 ML SOL UDS. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical products from its facility in Conshohocken, Pennsylvania to fulfill DLA's requirements under the contract. The single day period of performance from August 8 to August 9, 2023 indicates this was likely an urgent, small purchase to support DLA's medical supply chain responsibilities for the U.S. military. No subcontractors or set aside designations were identified.

Generated 12/20/23, 4:41 AM